InvestorsHub Logo
icon url

Walshballs

09/17/13 7:18 AM

#14144 RE: KCSVEN #14143

That is a major concern IF first off anchor is approved and there is no delay. GiA will kill any momo pps rise event. Initially the pps will rise but they will have to do another round of dilution to market anchor. Another reason I am in the buyout camp. This just drags out success much further out!
icon url

BioChica

09/17/13 8:12 AM

#14151 RE: KCSVEN #14143

Generally in Biomed's the stock is valued at potential sales for a drug/pipeline. Not the actual value, good chance of the PPS doubling. Look at CLDX up from 3's to $25 based not on sales/pipeline potential. They are years from actually selling anything. Hope this helps!
icon url

Dancing in the dark

09/17/13 8:57 AM

#14156 RE: KCSVEN #14143

"Imagine JZ announces we are not partnering for Anchor...won't WS sell off on that..?"

depends on what they do with the $500M, doesn't it? ;)